These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17101680)

  • 1. Activities of antimicrobial peptides and synergy with enrofloxacin against Mycoplasma pulmonis.
    Fassi Fehri L; Wróblewski H; Blanchard A
    Antimicrob Agents Chemother; 2007 Feb; 51(2):468-74. PubMed ID: 17101680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures.
    Nir-Paz R; Prévost MC; Nicolas P; Blanchard A; Wróblewski H
    Antimicrob Agents Chemother; 2002 May; 46(5):1218-25. PubMed ID: 11959548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of avian mycoplasmas to enrofloxacin, sarafloxacin, tylosin, and oxytetracycline.
    Wang C; Ewing M; Aarabi SY
    Avian Dis; 2001; 45(2):456-60. PubMed ID: 11417828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities to fluoroquinolones in current and archived Mycoplasma gallisepticum and Mycoplasma synoviae isolates from meat-type turkeys.
    Gerchman I; Lysnyansky I; Perk S; Levisohn S
    Vet Microbiol; 2008 Oct; 131(3-4):266-76. PubMed ID: 18534788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
    Jordan FT; Forrester CA; Ripley PH; Burch DG
    Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
    Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
    Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of Mycoplasma gallisepticum in chickens after treatment with enrofloxacin without development of resistance.
    Reinhardt AK; Gautier-Bouchardon AV; Gicquel-Bruneau M; Kobisch M; Kempf I
    Vet Microbiol; 2005 Mar; 106(1-2):129-37. PubMed ID: 15737482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibilities of field isolates of Mycoplasma agalactiae to oxytetracycline, tylosin, enrofloxacin, spiramycin and lincomycin-spectinomycin.
    Loria GR; Sammartino C; Nicholas RA; Ayling RD
    Res Vet Sci; 2003 Aug; 75(1):3-7. PubMed ID: 12801456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cationic antimicrobial peptides with Mycoplasma pulmonis.
    Park HJ; Kang KM; Dybvig K; Lee BL; Jung YW; Lee IH
    FEBS Lett; 2013 Oct; 587(20):3321-6. PubMed ID: 23994526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to antimicrobial peptides and stress response in Mycoplasma pulmonis.
    Fehri LF; Sirand-Pugnet P; Gourgues G; Jan G; Wróblewski H; Blanchard A
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4154-65. PubMed ID: 16189093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of natural amphipathic peptides on viability, membrane potential, cell shape and motility of mollicutes.
    Béven L; Wróblewski H
    Res Microbiol; 1997 Feb; 148(2):163-75. PubMed ID: 9765797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mollicutes contamination: a new strategy for an effective rescue of cancer cell lines.
    Mariotti E; D'Alessio F; Mirabelli P; Di Noto R; Fortunato G; Del Vecchio L
    Biologicals; 2012 Jan; 40(1):88-91. PubMed ID: 22078664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
    Davis JL; Foster DM; Papich MG
    J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimicrobial susceptibility of Mycoplasma bovis isolated in Israel from local and imported cattle.
    Gerchman I; Levisohn S; Mikula I; Lysnyansky I
    Vet Microbiol; 2009 Jun; 137(3-4):268-75. PubMed ID: 19250777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
    Li Q; Bi X; Diao Y; Deng X
    Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat strains differ in susceptibility to maternal and fetal infection with Mycoplasma pulmonis.
    Reyes L; Shelton M; Riggs M; Brown MB
    Am J Reprod Immunol; 2004 Mar; 51(3):211-9. PubMed ID: 15209390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
    Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
    Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'.
    Pag U; Oedenkoven M; Sass V; Shai Y; Shamova O; Antcheva N; Tossi A; Sahl HG
    J Antimicrob Chemother; 2008 Feb; 61(2):341-52. PubMed ID: 18174202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro.
    Baş AL; Simşek A; Erganiş O; Corlu M
    Dtsch Tierarztl Wochenschr; 2005 Jun; 112(6):219-23. PubMed ID: 16028487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and determination of antimicrobial resistance of Mycoplasma gallisepticum isolated from chickens.
    Pakpinyo S; Sasipreeyajan J
    Vet Microbiol; 2007 Nov; 125(1-2):59-65. PubMed ID: 17570621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.